Cargando…

MicroRNAs: new players in IBD

MicroRNAs (miRNAs) are small non-coding RNAs, 18–23 nucleotides long, which act as post-transcriptional regulators of gene expression. miRNAs are strongly implicated in the pathogenesis of many common diseases, including IBDs. This review aims to outline the history, biogenesis and regulation of miR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalla, R, Ventham, N T, Kennedy, N A, Quintana, J F, Nimmo, E R, Buck, A H, Satsangi, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Recent Advances in Basic Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345829/ https://www.ncbi.nlm.nih.gov/pubmed/25475103 http://dx.doi.org/10.1136/gutjnl-2014-307891

Ejemplares similares

COVID-19 and immunomodulation in IBD
por: Neurath, Markus F
Publicado: (2020)

Liver sampling: a vital window into HBV pathogenesis on the path to functional cure
por: Gill, Upkar S, et al.
Publicado: (2018)

MicroRNAs as Potential Biomarkers for Childhood Epilepsy
por: Elnady, Hala G., et al.
Publicado: (2019)

Relation between microRNAs and Apoptosis in Hepatocellular Carcinoma
por: Kamel, Refaat R., et al.
Publicado: (2016)

Inflammatory Bowel Disease Associates with Proinflammatory Potential of the Immunoglobulin G Glycome
por: Trbojević Akmačić, Irena, et al.
Publicado: (2015)

Beyond Gene Discovery in Inflammatory Bowel Disease: The Emerging Role of Epigenetics
por: Ventham, Nicholas T., et al.
Publicado: (2013)

Gene expression and hepatitis C virus infection
por: Asselah, T, et al.
Publicado: (2009)

Big data in IBD: big progress for clinical practice
por: Seyed Tabib, Nasim Sadat, et al.
Publicado: (2020)

Regulatory T-cell therapy in Crohn’s disease: challenges and advances
por: Clough, Jennie N, et al.
Publicado: (2020)

The gut microbiota and host health: a new clinical frontier
por: Marchesi, Julian R, et al.
Publicado: (2016)

Epigenetics in liver disease: from biology to therapeutics
por: Hardy, Timothy, et al.
Publicado: (2016)

Role of the microbiome in human development
por: Dominguez-Bello, Maria Gloria, et al.
Publicado: (2019)

Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?
por: Hessmann, Elisabeth, et al.
Publicado: (2017)

Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells
por: Powell, Nick, et al.
Publicado: (2020)

Interferon lambdas: the next cytokine storm
por: Kelly, Christabel, et al.
Publicado: (2011)

The vagal innervation of the gut and immune homeostasis
por: Matteoli, Gianluca, et al.
Publicado: (2013)

Human gut microbiome: hopes, threats and promises
por: Cani, Patrice D
Publicado: (2018)

Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine
por: Conway, James RW, et al.
Publicado: (2019)

Protease inhibition as new therapeutic strategy for GI diseases
por: Vergnolle, Nathalie
Publicado: (2016)

Interaction between drugs and the gut microbiome
por: Weersma, Rinse K, et al.
Publicado: (2020)

The role of gut microbiota in cancer treatment: friend or foe?
por: Cheng, Wing Yin, et al.
Publicado: (2020)

Mucus barrier, mucins and gut microbiota: the expected slimy partners?
por: Paone, Paola, et al.
Publicado: (2020)

Liver organoids: from basic research to therapeutic applications
por: Prior, Nicole, et al.
Publicado: (2019)

Calprotectin: from biomarker to biological function
por: Jukic, Almina, et al.
Publicado: (2021)

Gut microbiome and health: mechanistic insights
por: de Vos, Willem M, et al.
Publicado: (2022)

Niche-specific functional heterogeneity of intestinal resident macrophages
por: Viola, Maria Francesca, et al.
Publicado: (2021)

Gut microbiota-derived metabolites as central regulators in metabolic disorders
por: Agus, Allison, et al.
Publicado: (2021)

From the origin of NASH to the future of metabolic fatty liver disease
por: Geier, Andreas, et al.
Publicado: (2021)

Dietary macronutrients and the gut microbiome: a precision nutrition approach to improve cardiometabolic health
por: Jardon, Kelly M, et al.
Publicado: (2022)

Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
por: Ting, Nick Lung-Ngai, et al.
Publicado: (2022)

Immunopathogenesis and environmental triggers in coeliac disease
por: Levescot, Anais, et al.
Publicado: (2022)

Organoids in gastrointestinal diseases: from experimental models to clinical translation
por: Günther, Claudia, et al.
Publicado: (2022)

Diet fuelling inflammatory bowel diseases: preclinical and clinical concepts
por: Adolph, Timon E, et al.
Publicado: (2022)

Advancing human gut microbiota research by considering gut transit time
por: Procházková, Nicola, et al.
Publicado: (2023)

Microbial transmission, colonisation and succession: from pregnancy to infancy
por: Xiao, Liwen, et al.
Publicado: (2023)

Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease
por: Ventham, N. T., et al.
Publicado: (2016)

Two-stage Genome-wide Methylation Profiling in Childhood-onset Crohn's Disease Implicates Epigenetic Alterations at the VMP1/MIR21 and HLA Loci
por: Adams, Alex T., et al.
Publicado: (2014)

A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction
por: Jaguszewski, Milosz, et al.
Publicado: (2014)

Correction: Changes to Serum Sample Tube and Processing Methodology Does Not Cause Inter-Individual Variation in Automated Whole Serum N-Glycan Profiling in Health and Disease
por: Ventham, Nicholas T., et al.
Publicado: (2015)

Changes to Serum Sample Tube and Processing Methodology Does Not Cause Inter-Individual Variation in Automated Whole Serum N-Glycan Profiling in Health and Disease
por: Ventham, Nicholas T., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_blsab7t5vmufpn87f98ras0dlv